These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16733631)

  • 21. Program-level predictors of antipsychotic medication adherence among parolees.
    Farabee D; Shen H; Sanchez S
    Int J Offender Ther Comp Criminol; 2004 Oct; 48(5):561-71. PubMed ID: 15358931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion.
    Sellwood W; Tarrier N; Quinn J; Barrowclough C
    Psychol Med; 2003 Jan; 33(1):91-6. PubMed ID: 12537040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
    Morken G; Grawe RW; Widen JH
    J Clin Psychiatry; 2007 Apr; 68(4):566-71. PubMed ID: 17474812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
    J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic medication adherence in schizophrenia.
    Byerly MJ; Nakonezny PA; Lescouflair E
    Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
    Nakonezny PA; Byerly MJ
    Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peers experience of delivering a problem-solving programme to enhance antipsychotic medication adherence for individuals with schizophrenia.
    Boardman G; Kerr D; McCann T
    J Psychiatr Ment Health Nurs; 2015 Aug; 22(6):423-30. PubMed ID: 25944402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of perceived social support on medication adherence in first-episode psychosis.
    Rabinovitch M; Cassidy C; Schmitz N; Joober R; Malla A
    Can J Psychiatry; 2013 Jan; 58(1):59-65. PubMed ID: 23327758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial.
    Perlick DA; Rosenheck RA; Kaczynski R; Swartz MS; Canive JM; Lieberman JA
    Schizophr Res; 2010 Feb; 116(2-3):118-25. PubMed ID: 19864114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Course of adherence to medication and quality of life in people with schizophrenia.
    Puschner B; Angermeyer MC; Leese M; Thornicroft G; Schene A; Kikkert M; Burti L; Tansella M; Becker T
    Psychiatry Res; 2009 Feb; 165(3):224-33. PubMed ID: 19155070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a structural model explaining medication compliance of persons with schizophrenia.
    Seo MA; Min SK
    Yonsei Med J; 2005 Jun; 46(3):331-40. PubMed ID: 15988803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
    Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
    Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia.
    Sohler NL; Walkup J; McAlpine D; Boyer C; Olfson M
    Psychiatr Serv; 2003 Sep; 54(9):1258-63. PubMed ID: 12954943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.